NEW YORK, July 7 - RNA interference firms Alnylam and Ribopharma today said they have merged and that the combined entity has raised an additional round of € 21.5 million ($24.6 million) in private equity financing.
...and receive Daily News bulletins.
Already have an account?Login Now.
Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.
Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.
Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.
In Science this week: gut microbiome influences liver cancer growth, spread; and more.